Selectivity of antiviral effectiveness derived from differences of herpes simplex virus-coded thymidine kinases.
D000212:Acyclovir / Q000633:toxicity*; D000818:Animals; D000998:Antiviral Agents / Q000633:toxicity*; D001973:Bromodeoxyuridine / Q000031:analogs & derivatives* / Q000633:toxicity; D002460:Cell Line; D002522:Chlorocebus aethiops; D007668:Kidney; D018139:Simplexvirus / Q000187:drug effects / Q000235:genetics*; D013937:Thymidine Kinase / Q000235:genetics* / Q000302:isolation & purification
D000998:Antiviral Agents; C020235:brivudine; D013937:Thymidine Kinase; D001973:Bromodeoxyuridine; D000212:Acyclovir